| Authors: |
Iavarone L; Parexel International, Milan, Italy., Lavezzi SM; Parexel International, Dublin, Ireland., Carcas AJ; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, and School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Chaychenko T; GSK, London, UK., Gabarro-Carrion R; GSK, Tres Cantos, Spain., Huertas AGLL; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, and School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Gresham S; GSK, Stevenage, UK., Marín-Candón A; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, and School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Penman SL; GSK, London, UK., Rolfe K; GSK, London, UK., Tiberi S; GSK, London, UK.; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Barros-Aguirre D; GSK, Tres Cantos, Spain., Borobia AM; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, and School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. |
